Brenda P. Nicholson, MD

Articles by Brenda P. Nicholson, MD

Paclitaxel, UFT, and Calcium Folinate in Metastatic Breast Cancer

ByNatalie R. Dickson, MD,Brenda P. Nicholson, MD,David Johnson, MD,Alan Cohen, MD

July 1st 1999

This is a phase I dose-escalation study of uracil and tegafur (in a molar ratio of 4:1 [UFT]) administered in combination with calcium folinate and paclitaxel in metastatic breast cancer. This trial was initiated to 1)

Latest Updated Articles

Paclitaxel, UFT, and Calcium Folinate in Metastatic Breast Cancer
July 1st 1999

Trending on CancerNetwork

Did ASCO 2026 Deliver on Its Biggest Pre-Meeting Predictions?

Why CELMoDs Pair Synergistically With PIs and CD38 Antibodies in Multiple Myeloma

26 A Nomogram for Predicting High Axillary Disease Burden in Patients With Localized HR+, HER2-Negative Breast Cancer Following Neoadjuvant Chemotherapy